Literature DB >> 22493078

Heart rate reduction: an old and novel candidate heart failure therapy.

Yonggang Ma, Robert J Chilton, Merry L Lindsey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22493078      PMCID： PMC3996900          DOI： 10.1161/HYPERTENSIONAHA.111.186494

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  12 in total

1.  Divergent effects of losartan and metoprolol on cardiac remodeling, c-kit+ cells, proliferation and apoptosis in the left ventricle after myocardial infarction.

Authors:  Raisa Serpi; Anna-Maria Tolonen; Olli Tenhunen; Oskari Pieviläinen; Anna-Maria Kubin; Tommi Vaskivuo; Ylermi Soini; Risto Kerkelä; Hanna Leskinen; Heikki Ruskoaho
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

2.  Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslipidemic atherosclerotic mice.

Authors:  Virginie Bolduc; Annick Drouin; Marc-Antoine Gillis; Natacha Duquette; Nathalie Thorin-Trescases; Isabelle Frayne-Robillard; Christine Des Rosiers; Jean-Claude Tardif; Eric Thorin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-16       Impact factor: 4.733

3.  Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Authors:  Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi
Journal:  Lancet       Date:  2010-09-11       Impact factor: 79.321

4.  Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and β-receptor blockade.

Authors:  Peter Moritz Becher; Diana Lindner; Kapka Miteva; Konstantinos Savvatis; Christin Zietsch; Bastian Schmack; Sophie Van Linthout; Dirk Westermann; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Hypertension       Date:  2012-04-09       Impact factor: 10.190

Review 5.  I f inhibition with ivabradine : electrophysiological effects and safety.

Authors:  Irina Savelieva; A John Camm
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Florian Custodis; Magnus Baumhäkel; Nils Schlimmer; Franka List; Christoph Gensch; Michael Böhm; Ulrich Laufs
Journal:  Circulation       Date:  2008-04-28       Impact factor: 29.690

7.  Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats.

Authors:  Gareth L Ackland; Song T Yao; Alain Rudiger; Alex Dyson; Ray Stidwill; Dmitry Poputnikov; Mervyn Singer; Alexander V Gourine
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

8.  Effects of AT1- and beta-adrenergic receptor antagonists on TGF-beta1-induced fibrosis in transgenic mice.

Authors:  U Seeland; A Schäffer; S Selejan; M Hohl; J-C Reil; P Müller; S Rosenkranz; M Böhm
Journal:  Eur J Clin Invest       Date:  2009-06-11       Impact factor: 4.686

9.  Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.

Authors:  Paul Mulder; Stephane Barbier; Abdeslam Chagraoui; Vincent Richard; Jean Paul Henry; Françoise Lallemand; Sylvanie Renet; Guy Lerebours; Florence Mahlberg-Gaudin; Christian Thuillez
Journal:  Circulation       Date:  2004-02-23       Impact factor: 29.690

10.  Ivabradine reduces chemokine-induced CD4-positive lymphocyte migration.

Authors:  Thomas Walcher; Peter Bernhardt; Dusica Vasic; Helga Bach; Renate Durst; Wolfgang Rottbauer; Daniel Walcher
Journal:  Mediators Inflamm       Date:  2010-12-05       Impact factor: 4.711
View more
  4 in total

Review 1.  Immune Modulation in Heart Failure: the Promise of Novel Biologics.

Authors:  Paulino Alvarez; Alexandros Briasoulis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-15

2.  Heart rate differentiates urgency and emergency in hypertensive crisis.

Authors:  Rashed Al Bannay; Michael Böhm; Aysha Husain
Journal:  Clin Res Cardiol       Date:  2013-04-28       Impact factor: 5.460

3.  Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation.

Authors:  Yonggang Ma; Ganesh V Halade; Jianhua Zhang; Trevi A Ramirez; Daniel Levin; Andrew Voorhees; Yu-Fang Jin; Hai-Chao Han; Anne M Manicone; Merry L Lindsey
Journal:  Circ Res       Date:  2012-12-20       Impact factor: 17.367

Review 4.  Heart rate reduction in coronary artery disease and heart failure.

Authors:  Roberto Ferrari; Kim Fox
Journal:  Nat Rev Cardiol       Date:  2016-05-26       Impact factor: 32.419
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.